APZ Aptilon Corporation

MONTREAL, July 5, 2012 /CNW/ - Aptilon Corporation ("Aptilon" or the "Company") , a leader in online access, engagement and interaction with physicians and healthcare professionals on behalf of pharmaceutical and life sciences companies, today announced that while its audit is progressing, more time is required to finalize the Company's audited annual financial statements for the year ended December 31, 2011, including the related management discussion and analysis, and CEO and CFO certifications (collectively, the "Annual Financial Filings") and the equivalent filings for the period ended March 31, 2012 (the "Interim Financial Filings"). The Company expects that the Annual Financial Filings and the Interim Financial Filings will be filed simultaneously by July 31, 2012. In light of this change, the Management cease-trade order granted on May 4 until June 29 by the Autorité des marchés financiers (the "AMF") will not be extended and the AMF has issued a full cease-trade order in its place. In addition, IIROC has announced a trading halt on Aptilon's shares effective immediately. About Aptilon Corporation Aptilon enables pharmaceutical, biotech and medical device companies to effectively reach, message, connect and interact with US physicians and healthcare professionals via multiple access channels. Its innovative service offerings provide targeted impressions and interactions through: video and mobile detailing, ReachNet(SM) Physician Access Channel, the DMD database and permission-based email services. Top US pharmaceutical companies and respected healthcare organizations have adopted Aptilon's solutions to market to, engage and interact with leading healthcare practitioners. For more information, visit www.aptilon.com. ReachNet(SM) is a service mark of Aptilon Corporation, other trademarks are the property of their respective owners. Forward-looking statements This news release contains discussion of items that may constitute forward-looking statements within the meaning of securities laws that involve risks and uncertainties. Such statements include those with respect to the date on which the Annual Financial Filings and the Interim Financial Filings will be filed. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be achieved. Such assumptions, which may prove incorrect, include the following: (i) the audit of the Company's 2011 financial statements will be completed during the month of July, (ii) the auditors will be in a position to issue an auditor's report without reservations upon the completion of their audit, and (iii) the Company will be in a position to file the Annual Financial Filings and the Interim Financial Filings shortly after the audit is complete. Factors that could cause actual results to differ materially from expectations include (i) the inability of the Company's auditors to complete their audit during the month of July, (ii) the inability of the auditors to issue an unqualified auditor's report upon the completion of their audit and (iii) the Company's inability to file the Annual Filings or the Interim Financial Filings for any other reason. These factors and others are more fully discussed in the Company's filings with Canadian securities regulatory authorities available at www.sedar.com. Actual results may vary from the forward-looking information. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Aptilon Corporation CONTACT: Mr. Denis MartineauPresidentAptilon Corporation1-888-544-8866investors@aptilon.com

Copyright